2,2',3,5',6-pentachlorobiphenyl has been researched along with Nervous System Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertson, TE; Joy, RM; Pessah, IN; Schantz, SL; Wong, PW | 1 |
1 other study(ies) available for 2,2',3,5',6-pentachlorobiphenyl and Nervous System Disorders
| Article | Year |
|---|---|
Ortho-substituted 2,2',3,5',6-pentachlorobiphenyl (PCB 95) alters rat hippocampal ryanodine receptors and neuroplasticity in vitro: evidence for altered hippocampal function.
Topics: Animals; Calcium; Calcium Channels; Electrophysiology; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Muscle Proteins; Nervous System Diseases; Neuronal Plasticity; Neurons; Polychlorinated Biphenyls; Pyramidal Cells; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Ryanodine Receptor Calcium Release Channel; Signal Transduction | 1997 |